Navigation Links
Pig Stem Cells Created
Date:6/3/2009

Organ transplants and other revolutionary uses predicted for humans, study says

WEDNESDAY, June 3 (HealthDay News) -- Using cells from pig ears and bone marrow, researchers in China generated a type of stem cell capable of developing into any type of cell in the body.

This is the first time researchers have created pluripotent stem cells using cells from a hooved animal that weren't derived from sperm or eggs. Like embryonic stem cells, pluripotent stem cells can differentiate into other types of cells.

The researchers hope their discovery will move scientists closer to genetically engineering pigs for organ transplants for humans and developing pigs that are resistant to diseases such as swine flu.

The study findings were published online June 3 in the Journal of Molecular Cell Biology.

"The pig species is significantly similar to humans in its form and function, and the organ dimensions are largely similar to human organs," lead study author Lei Xiao, who heads the stem-cell lab at the Shanghai Institute of Biochemistry and Cell Biology, said in a news release from the journal. "We could use embryonic stem cells or induced stem cells to modify the immune-related genes in the pig to make the pig organ compatible to the human immune system. Then we could use these pigs as organ donors to provide organs for patients that won't trigger an adverse reaction from the patient's own immune system."

Pig pluripotent stem-cell lines could also be used to help study human genetic diseases, Xiao noted.

"Many human diseases, such as diabetes, are caused by a disorder of gene expression," Xiao said in the news release. "We could modify the pig gene in the stem cells and generate pigs carrying the same gene disorder so that they would have a similar syndrome to that seen in human patients. Then it would be possible to use the pig model to develop therapies to treat the disease."

To induce the pluripotent cells, researchers used a virus to introduce transcription factors, which reprogram cells, to cells taken from a pig's ear and bone marrow. After the introduction of transcription factors, the cells developed in the lab into colonies of embryonic-like stem cells.

Further tests confirmed the cells were capable of differentiating into the cell types that make up the three layers in an embryo -- endoderm, mesoderm and ectoderm -- a characteristic of all embryonic stem cells.

The discovery will make it easier for researchers to develop embryonic stem cells from embryos of pigs and other hooved animals, known as ungulates, according to the study.

Although treatments in humans are several years away or more, Xiao said his next research will be using the induced pluripotent cells to generate gene-modified pigs that could provide organs for patients or aid in disease resistance.

The induced pluripotent cells could either be used to transfer an additional bit of genetic material (such as a piece of human DNA) into the pig's genome or to prevent a particular gene from functioning.

"This research is very exciting because it represents the first rigorous demonstration of the establishment of pluripotent stem cell in ungulate species, which will open up interesting opportunities for creating precise, gene-modified animals for research, therapeutic and agricultural purposes," said Dangsheng Li, the journal's editor-in-chief, in the news release.

More information

For more on stem cells, visit the U.S. National Institutes of Health's resource for stem cell research.



-- Jennifer Thomas



SOURCE: Journal of Molecular Cell Biology, news release, June 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Brain cells work differently than previously thought
3. Embryonic Stem Cells Repair Human Heart
4. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
5. Circulating fats kill transplanted pancreas cells, study shows
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Melanoma drug revs immune cells but cancer cells ignore it
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Embryonic stem cells used to grow cartilage
10. Molecular probe paints cancer cells in living animals, Stanford researchers find
11. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pig Stem Cells Created
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: